Anthropometric measures and risk of epithelial ovarian cancer: Results from the nurses' health study

Obesity

Volumn 18, Issue 8, 2010, Pages 1625-1631

  Kotsopoulos, Joanne ^a   Baer, Heather J ^a,b   Tworoger, Shelley S ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; COHORT ANALYSIS; FEMALE; HEALTH SURVEY; HUMAN; MENOPAUSE; MIDDLE AGED; MORPHOMETRICS; NEOPLASM; OVARY TUMOR; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; BODY MASS INDEX; BODY WEIGHT; BODY WEIGHTS AND MEASURES; COHORT STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; MENOPAUSE; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 77955057257     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.461     Document Type: Article

References (40)

1. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004;4:579-591.
2. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-578.
3. Tworoger SS, Eliassen AH, Missmer SA et al. Birthweight and body size throughout life in relation to sex hormones and prolactin concentrations in premenopausal women. Cancer Epidemiol Biomarkers Prev 2006;15: 2494-2501.
4. Schouten LJ, Rivera C, Hunter DJ et al. Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev 2008;17:902-912.
5. Olsen CM, Nagle CM, Whiteman DC et al.; Australian Cancer Study (Ovarian Cancer) and Australian Ovarian Cancer Study Group. Body size and risk of epithelial ovarian and related cancers: a population-based case-control study. Int J Cancer 2008;123:450-456.
6. Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 1998;90:1774-1786.
7. Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 2008;117:1658-1667.
8. Rimm EB, Stampfer MJ, Colditz GA et al. Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1990;1:466-473.
9. Tworoger SS, Gertig DM, Gates MA, Hecht JL, Hankinson SE. Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer. Cancer 2008;112:1169-1177.
10. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
11. Baer HJ, Hankinson SE, Tworoger SS. Body size in early life and risk of epithelial ovarian cancer: results from the Nurses' Health Studies. Br J Cancer 2008;99:1916-1922.
12. Fairfield KM, Willett WC, Rosner BA et al. Obesity, weight gain, and ovarian cancer. Obstet Gynecol 2002;100:288-296.
13. Dal Maso L, Franceschi S, Negri E et al. Body size indices at different ages and epithelial ovarian cancer risk. Eur J Cancer 2002;38:1769-1774.
14. Anderson J P, Ross JA, Folsom AR. Anthropometric variables, physical activity, and incidence of ovarian cancer: The Iowa Women's Health Study. Cancer 2004;100:1515-1521.
15. Hoyo C, Berchuck A, Halabi S et al. Anthropometric measurements and epithelial ovarian cancer risk in African-American and White women. Cancer Causes Control 2005;16:955-963.
16. Pischon T, Nöthlings U, Boeing H. Obesity and cancer. Proc Nutr Soc 2008;67:128-145.
17. Snijder MB, Dekker JM, Visser M et al. Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am J Clin Nutr 2003;77:1192-1197.
18. Willett W. Anthropometric Measures and Body Composition. Nutritional Epidemiology, 2nd edn. Oxford Press: New York, 1998, pp 245-272.
19. Willett W. Nutritional Epidemiology, 2nd edn. Oxford University Press: Oxford, 1998.
20. Farrow DC, Weiss NS, Lyon JL, Daling JR. Association of obesity and ovarian cancer in a case-control study. Am J Epidemiol 1989;129: 1300-1304.
21. Møller H, Mellemgaard A, Lindvig K, Olsen JH. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 1994;30A:344-350.
22. Purdie DM, Bain CJ, Webb PM et al. Body size and ovarian cancer: case-control study and systematic review (Australia). Cancer Causes Control 2001;12:855-863.
23. Kuper H, Cramer DW, Titus-Ernstoff L. Risk of ovarian cancer in the United States in relation to anthropometric measures: does the association depend on menopausal status? Cancer Causes Control 2002;13:455-463.
24. Engeland A, Tretli S, Bjørge T. Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women. J Natl Cancer Inst 2003;95:1244-1248.
25. Peterson NB, Trentham-Dietz A, Newcomb PA et al. Relation of anthropometric measurements to ovarian cancer risk in a population-based case-control study (United States). Cancer Causes Control 2006;17:459-467.
26. Beehler G P, Sekhon M, Baker JA et al. Risk of ovarian cancer associated with BMI varies by menopausal status. J Nutr 2006;136:2881-2886.
27. Byers T, Marshall J, Graham S, Mettlin C, Swanson M. A case-control study of dietary and nondietary factors in ovarian cancer. J Natl Cancer Inst 1983;71:681-686.
28. Lukanova A, Björ O, Kaaks R et al. Body mass index and cancer: results from the Northern Sweden Health and Disease Cohort. Int J Cancer 2006;118:458-466.
29. IARC. International Agency for Research on Cancer: Lyon, 2002.
30. Ballard-Barbash R, Swanson CA. Body weight: estimation of risk for breast and endometrial cancers. Am J Clin Nutr 1996;63:437S-441S.
31. Helzlsouer KJ, Alberg AJ, Gordon GB et al. Serum gonadotropins and steroid hormones and the development of ovarian cancer. JAMA 1995;274:1926-1930.
32. Lukanova A, Lundin E, Akhmedkhanov A et al. Circulating levels of sex steroid hormones and risk of ovarian cancer. Int J Cancer 2003;104: 636-642.
33. Tworoger SS, Lee IM, Buring JE, Hankinson SE. Plasma androgen concentrations and risk of incident ovarian cancer. Am J Epidemiol 2008;167:211-218.
34. Rinaldi S, Dossus L, Lukanova A et al. Endogenous androgens and risk of epithelial ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol Biomarkers Prev 2007;16:23-29.
35. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 1997;350:1047-1059.
36. Rodriguez C, Calle EE, Fakhrabadi-Shokoohi D, Jacobs EJ, Thun MJ. Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 2002;11:822-828.
37. Mascarenhas C, Lambe M, Bellocco R et al. Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival. Int J Cancer 2006;119:2907-2915.
38. Nagle CM, Bain CJ, Green AC, Webb PM. The influence of reproductive and hormonal factors on ovarian cancer survival. Int J Gynecol Cancer 2008;18:407-413.
39. Greer JB, Modugno F, Ness RB, Allen GO. Anthropometry and the risk of epithelial ovarian cancer. Cancer 2006;106:2247-2257.
40. Schouten LJ, Goldbohm RA, van den Brandt PA. Height, weight, weight change, and ovarian cancer risk in the Netherlands cohort study on diet and cancer. Am J Epidemiol 2003;157:424-433.